Kedudukan dalam Saham
#15300
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Harga Saham
$6.64
Disegerakkan terakhir: 2026-08-31
Perubahan (1 hari)
-0.82%
Perubahan (1 tahun)
-61.27%
Perdagangan Upstream Bio, Inc. (UPB)
Harga UPB dengan permodalan pasaran b
Modal pasaran bagi Upstream Bio, Inc.(UPB)
Modal Pasaran: $361.08M
Sehingga September 2026, Upstream Bio, Inc. mempunyai modal pasaran sebanyak $361.08M. Ini menjadikan Upstream Bio, Inc. syarikat ke-15300th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Upstream Bio, Inc. dari 2024 hingga 2026
UPB berbanding dengan 5 teratas yang paling popular stocks
| Harga UPB |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.327T
|
+1,475,155.75%
|
|
|
|
|
$4.645T
|
+1,286,296.34%
|
|
|
|
|
$4.070T
|
+1,127,156.70%
|
|
|
|
|
$3.785T
|
+1,048,037.71%
|
|
|
|
|
$2.790T
|
+772,623.21%
|
